Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$9.02 USD
+0.92 (11.36%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $9.03 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.25 | 0.00% |
Earnings Summary
For their last quarter, Atara Biotherapeutics (ATRA) reported earnings of -$5.75 per share, beating the Zacks Consensus Estimate of $-9.25 per share. This reflects a positive earnings surprise of 37.84%. Look out for ATRA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.25 per share, reflecting a year-over-year increase of 92.65%.
Earnings History
Price & Consensus
Zacks News for ATRA
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
ATRA: What are Zacks experts saying now?
Zacks Private Portfolio Services